Comorbidities in Adult Attention-Deficit/Hyperactivity Disorder: A Practical Guide to Diagnosis in Primary Care

References

• . Kessler RC, Adler L, Barkley R, . The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716–723
   PubMed Web of Science ®Google Scholar
• . American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition. Washington, DC: American Psychiatric Association; 2013
   Google Scholar
• . Solanto MV, Wasserstein J, Marks DJ, Mitchell KJ. Diagnosis of ADHD in adults: what is the appropriate DSM-5 symptom threshold for hyperactivity-impulsivity? J Atten Disord. 2012;16(8):631–634
   PubMed Web of Science ®Google Scholar
• . American Psychiatric Association. Attention-deficit and disruptive behavior disorders. Diagnostic and Statistical Manual of Mental Disorders, 4th ed, text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000:85–93
   Google Scholar
• . Babcock T, Ornstein CS. Comorbidity and its impact in adult patients with attention-deficit/hyperactivity disorder: a primary care perspective. Postgrad Med. 2009;121(3):73–82
   PubMed Web of Science ®Google Scholar
• . Primich C, Iennaco J. Diagnosing adult attention-deficit hyperactivity disorder: the importance of establishing daily life contexts for symptoms and impairments. J Psychiatr Ment Health Nurs. 2012;19(4):362–373
   PubMed Web of Science ®Google Scholar
• . Wilens TE, Dodson W. A clinical perspective of attention-deficit/hyperactivity disorder into adulthood. J Clin Psychiatry. 2004;65(10):1301–1313
   PubMed Web of Science ®Google Scholar
• . Adler LA. Diagnosing and treating adult ADHD and comorbid conditions. J Clin Psychiatry. 2008;69(11):e31
   PubMedGoogle Scholar
• . Adler L, Cohen J. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2004;27(2):187–201
   PubMed Web of Science ®Google Scholar
• . Barkley RA. Primary symptoms, diagnostic criteria, prevalence, and gender differences. In: Barkley RA, ed. Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment, 3rd ed. New York: Guilford Press; 2005:76–121
   Google Scholar
• . Kooij JJ, Huss M, Asherson P, . Distinguishing comorbidity and successful management of adult ADHD. J Atten Disord. 2012;16( 5 suppl):3S–19S
   PubMed Web of Science ®Google Scholar
• . Brook JS, Brook DW, Zhang C, Seltzer N, Finch SJ. Adolescent ADHD and adult physical and mental health, work performance, and financial stress. Pediatrics. 2013;131(1):5–13
   PubMed Web of Science ®Google Scholar
• . Frick PJ, Nigg JT. Adult ADHD Self-Report Scale (ASRS_v.1.1) Symptom Checklist. Annu Rev Clin Psychol. 2012;8:77–107
   PubMed Web of Science ®Google Scholar
• . Wingo AP, Ghaemi SN. Frequency of stimulant treatment and of stimulant-associated mania/hypomania in bipolar disorder patients. Psychopharmacol Bull. 2008;41(4):37–47
   PubMed Web of Science ®Google Scholar
• . Adler LA, Kessler RC, Spencer T. Adult ADHD Self-Report Scale-v1.1 (ASRS-v1.1) Symptom Checklist. World Health Organization. http://webdoc.nyumc.org/nyumc/files/psych/attachments/psych_adhd_checklist.pdf. Accessed June 26, 2013
   Google Scholar
• . Kessler RC, Adler LA, Gruber MJ, Sarawate CA, Spencer T, Van Brunt DL. Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members. Int J Methods Psychiatr Res. 2007;16(2):52–65
   PubMed Web of Science ®Google Scholar
• . Conners CK Erhardt D, Sparrow E. Conners' Adult ADHD Rating Scales, Technical Manual. New York: Multi-Health Systems Inc.; 1999
   Google Scholar
• . Weiss MD, Dickson R, Wasdell MB, Bomben MM, Caney SV. Weiss Functional Impairment Rating Scale—Parent Report (WFIRS-P). Presented at: American Psychiatric Association 158th Annual Meeting, May 21–26, 2005, Atlanta, GA
   Google Scholar
• . Brod M, Johnston J, Able S, Swindle R. Validation of the adult attention-deficit/hyperactivity disorder quality-of-life scale (AAQoL): a diseasespecific quality-of-life measure. Qual Life Res. 2006;15(1):117–129
   PubMed Web of Science ®Google Scholar
• . McIntosh D, Kutcher S, Binder C, Levitt A, Fallu A, Rosenbluth M. Adult ADHD and comorbid depression: a consensus-derived diagnostic algorithm for ADHD. Neuropsychiatr Dis Treat. 2009;5:137–150
   PubMed Web of Science ®Google Scholar
• . Wigal SB. Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults. CNS Drugs. 2009;23( suppl 1):21–31
   PubMed Web of Science ®Google Scholar
• . Cumyn L, French L, Hechtman L. Comorbidity in adults with attention-deficit hyperactivity disorder. Can J Psychiatry. 2009;54(10):673–683
   PubMed Web of Science ®Google Scholar
• . American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision. Washington, DC: American Psychiatric Association; 2000
   Google Scholar
• . Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD–7. Arch Intern Med. 2006;166(10):1092–1097
   PubMed Web of Science ®Google Scholar
• . Adler LA, Kunz M, Chua HC, Rotrosen J, Resnick SG. Attention-deficit/hyperactivity disorder in adult patients with posttraumatic stress disorder (PTSD): is ADHD a vulnerability factor? J Atten Disord. 2004;8(1):11–16
   PubMedGoogle Scholar
• . Harrington KM, Miller MW, Wolf EJ, Reardon AF, Ryabchenko KA, Ofrat S. Attention-deficit/hyperactivity disorder comorbidity in a sample of veterans with posttraumatic stress disorder. Compr Psychiatry. 2012;53(6):679–690
   PubMed Web of Science ®Google Scholar
• . Ford JD, Connor DF. ADHD and posttraumatic stress disorder. Current Attention Disorders Reports. 2009;1(2):60–66
   Google Scholar
• . Ruggiero KJ, Del Ben K, Scotti JR, Rabalais AE. Psychometric properties of the PTSD Checklist-Civilian Version. J Trauma Stress. 2003;16(5):495–502
   PubMed Web of Science ®Google Scholar
• . Kooij SJ, Bejerot S, Blackwell A, . European consensus statement on diagnosis and treatment of adult ADHD: the European Network Adult ADHD. BMC Psychiatry. 2010;10:67
   PubMed Web of Science ®Google Scholar
• . Rostain AL. Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management. Postgrad Med. 2008;120(3):27–38
   PubMed Web of Science ®Google Scholar
• . Bruggisser M, Bodmer M, Liechti ME. Severe toxicity due to injected but not oral or nasal abuse of methylphenidate tablets. Swiss Med Wkly. 2011;141:w13267
   PubMed Web of Science ®Google Scholar
• . Lott DC, Kim SJ, Cook EH Jr, de Wit H. Dopamine transporter gene associated with diminished subjective response to amphetamine. Neuropsychopharmacology. 2005;30(3):602–609
   PubMed Web of Science ®Google Scholar
• . Duong S, Chung K, Wigal SB. Metabolic, toxicological, and safety considerations for drugs used to treat ADHD. Expert Opin Drug Metab Toxicol. 2012;8(5):543–552
   PubMed Web of Science ®Google Scholar
• . Goodman D. Adult ADHD and comorbid depressive disorders: diagnostic challenges and treatment options. CNS Spectr. 2009;14(7 suppl 6): 5–7; discussion 13–14
   PubMed Web of Science ®Google Scholar
• . Ryden E, Thase ME, Straht D, . A history of childhood attention-deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD. Acta Psychiatr Scand. 2009;120(3):239–246
   PubMed Web of Science ®Google Scholar
• . Hirschfeld RM, Williams JB, Spitzer RL, . Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000;157(11):1873–1875
   PubMed Web of Science ®Google Scholar
• . Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613
   PubMed Web of Science ®Google Scholar
• . Zimmerman M, Martinez J, Attiullah N, Friedman M, Toba C, Boerescu DA. How should residual symptoms be defined in depressed patients who have remitted? Compr Psychiatry. 2013;54(2):91–96
   PubMed Web of Science ®Google Scholar
• . Biederman J, Wilens T, Mick E, Milberger S, Spencer TJ, Faraone SV. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry. 1995;152(11):1652–1658
   PubMed Web of Science ®Google Scholar
• . Carpentier PJ, van Gogh MT, Knapen LJ, Buitelaar JK, De Jong CA. Influence of attention deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone-maintained patients. Eur Addict Res. 2011;17(1):10–20
   PubMed Web of Science ®Google Scholar
• . Fatseas M, Debrabant R, Auriacombe M. The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders. Curr Opin Psychiatry. 2012;25(3):219–225
   PubMed Web of Science ®Google Scholar
• . Bukstein OG. Attention deficit hyperactivity disorder and substance use disorders. In: Stanford C, Tannock R, eds. Behavioral Neuroscience of Attention Deficit Hyperactivity Disorder and Its Treatment. Berlin: Springer-Verlag; 2011:145–172
   Google Scholar
• . McAweeney M, Rogers NL, Huddleston C, Moore D, Gentile JP. Symptom prevalence of ADHD in a community residential substance abuse treatment program. J Atten Disord. 2010;13(6):601–608
   PubMed Web of Science ®Google Scholar
• . Carpentier PJ, Knapen LJ, van Gogh MT, Buitelaar JK, De Jong CA. Addiction in developmental perspective: influence of conduct disorder severity, subtype, and attention-deficit hyperactivity disorder on problem severity and comorbidity in adults with opioid dependence. J Addict Dis. 2012;31(1):45–59
   PubMed Web of Science ®Google Scholar
• . Levin FR. Diagnosing attention-deficit/hyperactivity disorder in patients with substance use disorders. J Clin Psychiatry. 2007;68( suppl 11):9–14
   PubMed Web of Science ®Google Scholar
• . Bush B, Shaw S, Cleary P, Delbanco TL, Aronson MD. Screening for alcohol abuse using the CAGE questionnaire. Am J Med. 1987;82(2):231–235
   PubMed Web of Science ®Google Scholar
• . Knight JR, Sherritt L, Shrier LA, Harris SK, Chang G. Validity of the CRAFFT substance abuse screening test among adolescent clinic patients. Arch Pediatr Adolesc Med. 2002;156(6):607–614
   PubMed Web of Science ®Google Scholar
• . Czamara D, Tiesler CM, Kohlbock G, . Children with ADHD symptoms have a higher risk for reading, spelling and math difficulties in the GINIplus and LISAplus cohort studies. PLoS One. 2013;8(5):e63859
   PubMed Web of Science ®Google Scholar
• . Semrud-Clikeman M, Bledsoe J. Updates on attention-deficit/hyperactivity disorder and learning disorders. Curr Psychiatry Rep. 2011;13(5):364–373
   PubMed Web of Science ®Google Scholar
• . Barnes KA, Howard JH Jr, Howard DV, Kenealy L, Vaidya CJ. Two forms of implicit learning in childhood ADHD. Dev Neuropsychol. 2010;35(5):494–505
   PubMed Web of Science ®Google Scholar
• . Ginsberg Y, Hirvikoski T, Lindefors N. Attention deficit hyperactivity disorder (ADHD) among longer-term prison inmates is a prevalent, persistent and disabling disorder. BMC Psychiatry. 2010;10:112
   PubMed Web of Science ®Google Scholar
• . Lord C, Rutter M, Le Couteur A. Autism Diagnostic Interview–Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 1994;24(5):659–685
   PubMed Web of Science ®Google Scholar
• . Baron-Cohen S, Wheelwright S, Skinner R, Martin J, Clubley E. The autism-spectrum quotient (AQ): evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. J Autism Dev Disord. 2001;31(1):5–17
   PubMed Web of Science ®Google Scholar
• . Kessler RC, Coccaro EF, Fava M, Jaeger S, Jin R, Walters E. The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2006;63(6):669–678
   PubMed Web of Science ®Google Scholar
• . Biederman J, Faraone SV, Spencer T, Wilens T, Mick E, Lapey KA. Gender differences in a sample of adults with attention deficit hyperactivity disorder. Psychiatry Res. 1994;53(1):13–29
   PubMed Web of Science ®Google Scholar
• . Semiz UB, Basoglu C, Oner O, . Effects of diagnostic comorbidity and dimensional symptoms of attention-deficit-hyperactivity disorder in men with antisocial personality disorder. Aust N Z J Psychiatry. 2008;42(5):405–413
   PubMed Web of Science ®Google Scholar
• . Lampe K, Konrad K, Kroener S, . Neuropsychological and behavioural disinhibition in adult ADHD compared to borderline personality disorder. Psychol Med. 2007;37(12):1717–1729
   PubMed Web of Science ®Google Scholar
• . Ferrer M, Andion O, Matali J, . Comorbid attention-deficit/hyperactivity disorder in borderline patients defines an impulsive subtype of borderline personality disorder. J Pers Disord. 2010;24(6):812–822
   PubMed Web of Science ®Google Scholar
• . Krause-Utz A, Sobanski E, Alm B, . Impulsivity in relation to stress in patients with borderline personality disorder with and without co-occurring attention-deficit/hyperactivity disorder: an exploratory study. J Nerv Ment Dis. 2013;201(2):116–123
   PubMed Web of Science ®Google Scholar
• . Zanarini MC, Vujanovic AA, Parachini EA, Boulanger JL, Frankenburg FR, Hennen J. A screening measure for BPD: the McLean Screening Instrument for Borderline Personality Disorder (MSI-BPD). J Pers Disord. 2003;17(6):568–573
   PubMed Web of Science ®Google Scholar
• . Zanarini MC, Vujanovic AA, Parachini EA, Boulanger JL, Frankenburg FR, Hennen J. Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology. J Pers Disord. 2003;17(3):233–242
   PubMed Web of Science ®Google Scholar
• . Lieb K, Zanarini MC, Schmahl C, Linehan MM, Bohus M. Borderline personality disorder. Lancet. 2004;364(9432):453–461
   PubMed Web of Science ®Google Scholar
• . Canadian ADHD Practice Guidelines, 3rd ed. Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA); 2011. www.caddra.ca/cms4/index.php?option=com_content&view=article&id=26&Itemid=70&lang=en. Accessed August 6, 2014
   Google Scholar
• . Klassen LJ, Bilkey TS, Katzman M, Chokka P. Comorbid attention deficit/hyperactivity disorder and substance use disorder: treatment considerations. Curr Drug Abuse Rev. 2012;5(3):190–198
   PubMedGoogle Scholar
• . Robison RJ, Reimherr FW, Marchant BK, Faraone SV, Adler LA, West SA. Gender differences in 2 clinical trials of adults with attention-deficit/hyperactivity disorder: a retrospective data analysis. J Clin Psychiatry. 2008;69(2):213–221
   PubMed Web of Science ®Google Scholar
• . Rucklidge JJ. Gender differences in ADHD: implications for psychosocial treatments. Expert Rev Neurother. 2008;8(4):643–655
   PubMedGoogle Scholar
• . Connor DF, Steeber J, McBurnett K. A review of attention-deficit/hyperactivity disorder complicated by symptoms of oppositional defiant disorder or conduct disorder. J Dev Behav Pediatr. 2010;31(5):427–440
   PubMed Web of Science ®Google Scholar